Guardion Health Sciences Stock Price To Sales
Guardion Health Sciences fundamentals help investors to digest information that contributes to Guardion Health's financial success or failures. It also enables traders to predict the movement of Guardion Pink Sheet. The fundamental analysis module provides a way to measure Guardion Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardion Health pink sheet.
Guardion |
Guardion Health Sciences Company Price To Sales Analysis
Guardion Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Guardion Health Price To Sales | 0.36 X |
Most of Guardion Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardion Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Guardion Health Sciences has a Price To Sales of 0.3588 times. This is 98.32% lower than that of the Personal Care Products sector and significantly higher than that of the Consumer Staples industry. The price to sales for all United States stocks is 96.86% higher than that of the company.
Guardion Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardion Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Guardion Health could also be used in its relative valuation, which is a method of valuing Guardion Health by comparing valuation metrics of similar companies.Guardion Health is currently under evaluation in price to sales category among its peers.
Guardion Fundamentals
Return On Equity | -0.5 | |||
Return On Asset | -0.16 | |||
Profit Margin | 0.52 % | |||
Operating Margin | (18.75) % | |||
Current Valuation | (987.33 K) | |||
Shares Outstanding | 1.35 M | |||
Shares Owned By Insiders | 1.30 % | |||
Shares Owned By Institutions | 21.09 % | |||
Number Of Shares Shorted | 22.26 K | |||
Price To Earning | (0.71) X | |||
Price To Book | 0.32 X | |||
Price To Sales | 0.36 X | |||
Revenue | 12.25 M | |||
Gross Profit | 4.52 M | |||
EBITDA | (3.92 M) | |||
Net Income | 158.03 K | |||
Cash And Equivalents | 14.23 M | |||
Cash Per Share | 0.23 X | |||
Total Debt | 3.77 M | |||
Current Ratio | 11.28 X | |||
Book Value Per Share | 10.71 X | |||
Cash Flow From Operations | (4.37 M) | |||
Short Ratio | 0.18 X | |||
Earnings Per Share | (4.11) X | |||
Target Price | 40.0 | |||
Beta | 0.71 | |||
Market Capitalization | 4.39 M | |||
Total Asset | 11.92 M | |||
Retained Earnings | (93.57 M) | |||
Working Capital | 10.57 M | |||
Current Asset | 12.8 M | |||
Current Liabilities | 466.01 K | |||
Annual Yield | 1.75 % | |||
Net Asset | 11.92 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |